Debunked Episode 17: Is Big Pharma Prepared for Impact of Trump Administration’s Health Policies?

The Trump administration’s healthcare policy changes from the gutting of medical research grants to changes on the CDC vaccine board were the focus of the discussion on the latest episode of the Debunked Podcast with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch. The post Debunked Episode 17: Is…

Read More

Farewell to Medicare Advantage

By JEFF GOLDSMITH This morning, after twelve years, I dumped my Medicare Advantage plan and enrolled in a Medicare Supplement policy. My smoldering discontent finally boiled over and . . . I’m gone. It was a large network style national plan with zero premium. My decision to enroll in MA was, in part, ideological. I liked the…

Read More

Can the NIH replace all private sector clinical R&D?

A paper by Proudman et al. (2024) finds that doing so would be extremely expensive. Including all preclinical, clinical and post-approval R&D activities, total annual costs to maintain the average lifecycle level of 49.4 approved drugs across all disease areas during the 2018–22 period was estimated to be $139.6 billion. Including only pre-launch costs, total…

Read More

Healthcare AI: What’s in your chatbot?

By OWEN TRIPP So much of the early energy around generative AI in healthcare has been geared toward speed and efficiency: freeing doctors from admin tasks, automating patient intake, streamlining paperwork-heavy pain points. This is all necessary and helpful, but much of it boils down to established players optimizing the existing system to suit their…

Read More

Healthcare Benefit Trends Report: Managers Shift to More Independent Navigation, Embrace GLP-1 Drugs with Restrictions

[Sponsored] The 2025 Benefits Sentiment Index, a survey of 120 benefit consultants to self-insured employers, focuses on healthcare navigation, GLP-1 drug coverage and AI trends for healthcare benefits. The post Healthcare Benefit Trends Report: Managers Shift to More Independent Navigation, Embrace GLP-1 Drugs with Restrictions appeared first on MedCity News.

Read More